Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

8.290 +1.230 (+17.42%)
Streaming Delayed Price Updated: 12:41 PM EST, Feb 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
61 62 Next >
EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine
Via Benzinga
Novavax Stock Is a Bet on Interest From Unvaccinated People
NVAX stock represents a vaccine that lacks approval. There is real appeal behind the narrative, as it may appeal to unvaccinated people. 
Via InvestorPlace
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country 
Via Benzinga
Looking At Novavax's Recent Whale Trades
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
The COVID-19 pandemic has led to over 6 million fatalities. The scientists are still studying why most children do not suffer badly from coronavirus infection. 
Via Benzinga
Novavax's COVID-19 Vaccine Scores Green Light In India with First Approval For Adolescents
Via Benzinga
Why Novavax Stock Is Due for a Comeback Soon
As Novavax has its Covid-19 vaccine authorized in multiple major world markets, NVAX stock is overdue for a re-rating on Wall Street. 
Via InvestorPlace
5 Cheap Energy Stocks Riding Oil Higher
Energy is understandably at the top of every investor's mind right now, but finding the best energy stocks requires careful consideration. 
Via InvestorPlace
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Novavax’s Success Depends on the FDA’s Decision
While Novavax awaits FDA approval, the frustration amongst investors is rising and a lot is on stake. Take a small position in NVAX stock. 
Via InvestorPlace
This Is What Whales Are Betting On Novavax
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Will Another Covid Booster Save Vaccine Stocks Moderna, BioNTech?
Vaccine stocks remain under pressure despite a push for another round of Covid shots. 
Via Investor's Business Daily
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC
U.S. health experts warn that an emerging, highly contagious COVID-19 omicron variant, BA.2, could soon increase domestic coronavirus cases. 
Via Benzinga
Novavax Whale Trades For March 18
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Check Out What Whales Are Doing With NVAX
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 23 strange trades. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Investors Should Not Lose Faith in Novavax
The valuation of NVAX stock is quite attractive while Novavax continues to make progress in many important areas. 
Via InvestorPlace
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
The WHO Foundation CEO, Anil Soni, has told CNBC that the global economy will lose “trillions of dollars” if more COVID-19 vaccines aren& 
Via Benzinga
Check Out What Whales Are Doing With NVAX
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 14 strange trades. 
Via Benzinga
Best Biotech Stocks To Buy In 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and... 
Via Talk Markets
Hopes For A Peace Accord
The winner today was BioNTech up 14.89% on hopes for new sales for the Covid-19 variant. 
Via Talk Markets
Why Is Novavax (NVAX) Stock in the Spotlight Today?
Novavax is once again in the spotlight as China reports near-record numbers of Covid cases. What's going on with NVAX stock? 
Via InvestorPlace
NASDAQ:NVAX Long Term Investor Notice: Investigation of Potential Wrongdoing at Novavax, Inc.
San Diego, CA -- (SBWIRE) -- 03/14/2022 -- Certain directors of Novavax, Inc. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
50 Stocks Moving In Monday's Mid-Day Session
Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share. AgriFORCE Growing Systems,... 
Via Benzinga
Here's Why Pfizer And Novavax Shares Are Rising On Monday
Pfizer Inc. (NYSE:PFE) and Novavax, Inc. 
Via Benzinga
Chart Wars: Between Moderna And Novavax, Which COVID Stock Will Soar Higher?
Moderna, Inc (NASDAQ: MRNA) and Novavax, Inc (NASDAQ: NVAX) were trading up over 10% and 8%, respectively, at one point on Wednesday, boosted by the S&P 500’s... 
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 10.65% on an annualized basis. Buying $100 In NVAX: 5 years ago, an investor could have purchased 3.47... 
Via Benzinga
Novavax's COVID-19 Shot Inches Up To FDA Authorization: WSJ
Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine is moving toward U.S. authorization after the Company said it resolved manufacturing problems that had held up its... 
Via Benzinga
Novavax Revenue Guidance Does Little to Change Neutral Stance on the Stock
NVAX stock's revenue guidance may have given investors a reason to stay invested. However, risks continue to outweigh benefits. 
Via InvestorPlace
10 Biggest Price Target Changes For Thursday
Piper Sandler cut the price target on Bright Health Group, Inc. (NYSE: BHG) from $10 to $5. Bright Health shares rose 3.2% to $2.59 in pre-market trading. 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.